Circulating levels of IFN gammaand neutrophil counts in breast cancer patients who received balixafortide and eribulin combination therapy

Category Primary study
JournalCancer Research
Year 2019
This article has no abstract
Epistemonikos ID: 6d407aff937c4b4b83b11b36187eeccd81d590ab
First added on: Feb 11, 2025